These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2162062)

  • 41. [Plasmapheresis in multiple sclerosis].
    Fuchs S; Pogglitsch H; Ladurner G; Lechner H
    Wien Klin Wochenschr; 1984 Jan; 96(2):67-9. PubMed ID: 6710999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double-blind study of the effect of corticotropin treatment in multiple sclerosis.
    Boman K; Hokkanen E; Jarho L; Kivalo E
    Ann Med Intern Fenn; 1966; 55(3):71-3. PubMed ID: 4290702
    [No Abstract]   [Full Text] [Related]  

  • 43. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
    Goodkin DE
    West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Non-specific immunosuppression and multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):629-34. PubMed ID: 9809379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group.
    Ann Neurol; 1990 Jun; 27(6):591-605. PubMed ID: 2193613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A period of trial in American apheresis medicine.
    Weinstein R
    Transfus Apher Sci; 2001 Oct; 25(2):89-91. PubMed ID: 11761279
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunosuppressive effects of isoprinosine in man: a comparison to chlorambucil effects in multiple sclerosis.
    Pompidou A; Rancurel G; Delsaux MC; Meunier C; Telvi L; Cour V; Buge A
    Cancer Detect Prev Suppl; 1987; 1():377-83. PubMed ID: 2446758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.
    Kimiskidis V; Sakellari I; Tsimourtou V; Kapina V; Papagiannopoulos S; Kazis D; Vlaikidis N; Anagnostopoulos A; Fassas A
    Mult Scler; 2008 Mar; 14(2):278-83. PubMed ID: 17942513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs.
    Khatri BO; McQuillen MP; Harrington GJ; Schmoll D; Hoffmann RG
    Neurology; 1985 Mar; 35(3):312-9. PubMed ID: 3974889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. There are no alternatives to double-blind, controlled trials.
    Noseworthy JH
    Neurology; 1988 Jul; 38(7 Suppl 2):76-9. PubMed ID: 3290719
    [No Abstract]   [Full Text] [Related]  

  • 51. [Plasmapheresis in the treatment of neurologic disorders].
    Szobor A; Fornádi L; Vájlok M
    Orv Hetil; 1988 Jan; 129(3):119-23. PubMed ID: 3281091
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunological treatment of multiple sclerosis. II.
    Hughes RA
    J Neurol; 1986 Apr; 233(2):66-8. PubMed ID: 3009722
    [No Abstract]   [Full Text] [Related]  

  • 53. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris.
    Euler HH; Löffler H; Christophers E
    Arch Dermatol; 1987 Sep; 123(9):1205-10. PubMed ID: 3632005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
    Ryberg B; Pirskanen R
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):850-1. PubMed ID: 2996688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon beta treatment in multiple sclerosis: the European clinical trials.
    Comi G; Martinelli V; Filippi M
    Mult Scler; 1996 Jul; 1(6):317-20. PubMed ID: 9345407
    [No Abstract]   [Full Text] [Related]  

  • 56. [Apheresis for demyelinating diseases].
    Matsunaga M; Sato T
    Nihon Rinsho; 1992 Jan; 50 Suppl():345-50. PubMed ID: 1315881
    [No Abstract]   [Full Text] [Related]  

  • 57. A double-blind controlled pilot study of plasma exchange versus sham apheresis in chronic progressive multiple sclerosis.
    Gordon PA; Carroll DJ; Etches WS; Jeffrey V; Marsh L; Morrice BL; Olmstead D; Warren KG
    Can J Neurol Sci; 1985 Feb; 12(1):39-44. PubMed ID: 3884114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunosuppressant treatment in multiple sclerosis.
    van den Noort S
    Clin Neuropharmacol; 1985; 8(1):58-63. PubMed ID: 2983891
    [No Abstract]   [Full Text] [Related]  

  • 59. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1984; 18(3):259-62. PubMed ID: 6390235
    [No Abstract]   [Full Text] [Related]  

  • 60. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
    Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
    Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.